Skip to NavigationSkip to content


The value of measuring biotech Board performance

Published on 04/10/18 at 12:06pm

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life sciences, and offers guidance on how to manage this effectively.

Sanofi sends letter to Medivation board; claims shareholders want takeover

The CEO of Sanofi has issued a strongly worded letter to the board at Medivation, indicating that shareholders support their proposed takeover and that they would approach shareholders directly to have members of the board removed if their bids continued to be rebuffed.

Board at Medivation unanimously reject Sanofi bid

The board at Medivation has unanimously rejected the $9.8 billion takeover bid from Sanofi.

They declare that Sanofi’s bid of $52.50 per share “substantially undervalues” the company and is “not in the best interests of the company and its stockholders”.

Depomed criticised by investors and urged to explore potential sale

Only a few short months after fighting off a $1 billion bid from Horizon Pharma, investors at Depomed have called on the board to explore a potential sale of the company.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches